I am an internist and medical oncologist who specializes in the care of patients with leukemia and bone marrow failure syndromes, including acute myeloid leukemia and the myelodysplastic syndromes. As a member of the Leukemia Service at Memorial Sloan Kettering Cancer Center, I am committed to partnering with each of my patients to offer them the best possible care, incorporating innovative new therapies whenever possible.
In the laboratory I study molecular alterations in the hematopoietic (blood-forming) stem and progenitor cells that underlie the development of acute myeloid leukemia and the myelodysplastic syndromes. We believe that by studying these immature blood cells we will improve our understanding of what causes these diseases, as well as the mechanisms by which they may become resistant to standard therapies. I am also interested in identifying novel alterations in cell surface protein expression in these diseases to identify new therapeutic targets and to develop new diagnostic tests.